WITHDRAWAL: Cantú Syndrome: A New Case and Evolution of Clinical Conditions During First 2‐Year Follow‐Up
Abstract
WITHDRAWAL: A. Mattiucci, G. Girolomoni, M. Cassina, T. Zoller, F. Antoniazzi, and D. Schena, “Cantú Syndrome: A New Case and Evolution of Clinical Conditions During First 2‐Year Follow‐Up,” Clinical Case Reports 11, no. 3 (2023): e6928: https://doi.org/10.1002/ccr3.6928.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.